Mechanism of transcriptional repression by TEL/RUNX1 fusion protein

Molecules and Cells

Volumn 17, Issue 2, 2004, Pages 217-222

  Lee, Young Ju ^a   Kim, Jae Hyun ^a   Bae, Seonghwan ^a   Rho, Seung Keun ^a   Choe, Soo Young ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Dimerization; HDAC; Leukemia; TEL; TEL RUNX1; Transcription

Indexed keywords

DIMER; HELIX LOOP HELIX PROTEIN; HISTONE DEACETYLASE; HYBRID PROTEIN; PROTEIN P300; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; ACYLTRANSFERASE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; HYDROXAMIC ACID; ONCOPROTEIN; P300-CBP-ASSOCIATED FACTOR; PCAF PROTEIN, HUMAN; PROTEIN SYNTHESIS INHIBITOR; RUNX1 PROTEIN, HUMAN; TEL RUNX1 FUSION PROTEIN, HUMAN; TEL-RUNX1 FUSION PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS; TRICHOSTATIN A;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; DIMERIZATION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VIVO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; CHEMISTRY; CHROMOSOME 12; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LEUKEMIA; METABOLISM; PROTEIN CONFORMATION; REPORTER GENE;

ACETYLTRANSFERASES; ANIMALS; CELL CYCLE PROTEINS; CELL LINE; CHROMOSOMES, HUMAN, PAIR 12; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DIMERIZATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, REPORTER; HISTONE ACETYLTRANSFERASES; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA; ONCOGENE PROTEINS, FUSION; PROTEIN CONFORMATION; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 3442887728     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Adya, N., Stacy, T., Speck, N. A., and Liu, P. P. (1998) The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Mol. Cell. Biol. 18, 7432-7443.
2. Caligiuri, M. A., Strout, M. P., and Gilliland, D. G. (1997) Molecular biology of acute myeloid leukemia. Semin. Oncol. 24, 32-44.
3. Chakrabarti, S. R. and Nucifora, G. (1999) The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Bioehem. Biophys. Res. Commun. 264, 871-877.
4. Golub, T. R., Barker, G. F., Lovett, M., and Gilliland, D. G. (1994) Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77, 307-316.
5. Hiebert, S. W., Sun, W., Davis, J. N., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Groveld, G., Roussell, M. F., Gilliland, D. G., Lenny, N., and Meyers, S. (1996) The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16, 1349-1355.
6. Hiebert, S. W., Lutterbach, B., Durst, K., Wang, L., Linggi, B., Wu, S., Wood, L., Amann, J., King, D., and Hou, Y. (2001) Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins. Cancer Chemother Pharmacol. 48, S31-S34.
7. Ida, K., Kitabayashi, I., Kaki, T., Taniwaki, M., Noro, K., Yamamoto, M., Ohki, M., and Hayashi, Y. (1997) Adenovirus E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90, 4699-4704.
8. Kanno, Y., Kanno, T., Sakakura, C., Bae, S. C., and Ito, Y. (1998) Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation. Mol. Cell. Biol. 18, 4252-4261.
9. Kim, J. H., Lee, S., and Choe, S. Y. (1999a) Characterization of the human CR1 gene promoter. Biochem. Mol. Biol. Int. 47, 655-663.
10. Kim, J. H., Lee, S., Rho, J. K., and Choe, S. Y. (1999b) AML1, the target of chromosomal rearrangements in human leukemia, regulates the expression of human complement receptor type 1 (CR1) gene. Int. J. Biochem. Cell Biol. 31, 933-940.
11. Kim, C. A., Phillips, M. L., Kim, W., Gingery, M., Tran, H. H., Robinson, M. A., Faham, S., and Bowie, J. U. (2001) Polymerization of the SAM domain of TEL in leukomogenesis and transcriptional repression. EMBO J. 20, 4173-4182.
12. Kitabayashi, I., Yokoyama, A., Shimizu, K., and Ohki, M. (1998) Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 17, 2994-3004.
13. Look, A. T. (1997) Oncogenic transcription factors in human acute leukemia. Science 278, 1059-1064.
14. Lopez, R. G., Carron, C., Oury, C., Gardellin, P., Bernard, O., and Ghysdael, J. (1999) TEL is a sequence-specific transcriptional repressor. J. Biol. Chem. 274, 30132-30138.
15. Meyers, S., Lenny, N., and Hiebert, S. W. (1995) The t(8:21) fusion protein interferes with AML1 B-dependent transcriptional activation. Mol. Cell. Biol. 15, 1974-1982.
16. Okada, B., Watanabe, T., Niki, M., Takano, B., Chiba, N., Yanai, N., Tani, K., Hibino, H., Asano, S., Mucenski, M. L., Ito, Y., Noda, T., and Satake, M. (1998) AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene 17, 2287-2293.
17. Okuda, T., vanDeursen, J., Hiebert, S. W., Grosveld, G., and Downing, J. R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
18. Rho, J. K., Kim, J. H., Yu, J., and Choe, S. Y. (2002) Correlation between cellular localization of TEL/AML1 fusion protein and repression of AML1-mediated transactivation of CR1 gene. Biochem. Biophys. Res. Commun. 297, 91-95.
19. Shurtleff, S. A., Buijs, A., Behm, F. G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G. C., Pui, C. H., Grosveld, G., and Downing, J. R. (1995) TEL/AML1 fusion resulting from a cryptic t(12:21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9, 1985-1989.
20. Song, H., Kim, J. H., Rho, J. K., Park, S. Y., Kim, C. G., and Choe, S. Y. (1999) Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter. Mol. Cells 9, 560-563.
21. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. B., and Speck, N. A. (1996) Disruption of the cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93, 3444-3449.
22. Yagasaki, F., Jinnai, I., Yoshida, S., Yokoyama, Y., Matsuda, A., Kusumoto, S., Kobayashi, H., Terasaki, H., Ohyashiki, K., Asou, N., Murohashi, J., Bessho, M., and Hirashima, K. (1999) Fusion of TEL/ETV6 to a novel ACS2 in myelodys-plastic syndrome and acute myelogenous leukemia with the t(5;12)(q31;p13). Genes Chromosomes Cancer 26, 192-202.